Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$90.91 - $112.75 $45,364 - $56,262
499 New
499 $52,000
Q1 2023

May 17, 2023

BUY
$122.57 - $153.67 $1,103 - $1,383
9 Added 2.9%
319 $39,000
Q4 2022

Feb 13, 2023

BUY
$118.43 - $186.05 $36,713 - $57,675
310 New
310 $46,000
Q3 2021

Nov 05, 2021

SELL
$205.93 - $447.23 $43,039 - $93,471
-209 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$113.32 - $241.49 $23,683 - $50,471
209 New
209 $47,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.